Today: 30 April 2026
Browse Category

Stock Market 31 December 2025

Goldman Sachs stock slips on New Year’s Eve as Fed repo borrowing hits a record

Goldman Sachs stock slips on New Year’s Eve as Fed repo borrowing hits a record

Goldman Sachs shares fell 0.3% to $881.64 in thin year-end trading Wednesday. The New York Fed’s repo facility saw record borrowing at $74.6 billion, underscoring strong demand for cash. Wall Street’s main indexes edged lower, with the Dow down 0.19% and the S&P 500 off 0.15%. Investors are watching for Goldman’s Jan. 15 earnings and the Fed’s Jan. 27-28 meeting.
31 December 2025
Pitney Bowes NT 43 drops 3% today as Treasury yields rise — what’s next for PBI.PRB

Pitney Bowes NT 43 drops 3% today as Treasury yields rise — what’s next for PBI.PRB

Pitney Bowes’ NT 43 notes fell 3.0% to $21.04 Wednesday as U.S. 10-year yields rose and year-end trading thinned. About 50,000 shares changed hands, with prices ranging from $21.00 to $21.72. The drop followed a recent cash tender offer, with $75.7 million of the notes accepted for purchase out of $425 million outstanding. Pitney Bowes’ common shares slipped 0.85% to $10.56.
31 December 2025
Endeavour Silver stock falls in New York trade as silver rout hits miners ahead of China export curbs

Endeavour Silver stock falls in New York trade as silver rout hits miners ahead of China export curbs

Endeavour Silver shares fell 2.7% to $9.54 in New York on Wednesday, with about 9.3 million shares traded. The drop followed CME Group’s second margin hike on gold and silver futures in a week and China’s move to tighten silver export controls. Silver surged 161% in 2025, breaking $80 an ounce. Endeavour’s Terronera mine in Mexico began commercial production in October.
Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

Exxon Mobil shares slipped 0.6% to $120.22 in afternoon trading Wednesday as oil prices hovered near $61 a barrel for Brent and $58 for WTI. U.S. crude inventories fell by 1.9 million barrels last week, but gasoline and distillate stocks rose sharply. Investors are watching the Jan. 4 OPEC+ meeting and late-January earnings for direction. Other oil majors were mixed to lower.
31 December 2025
MarineServices brings workboat ‘Puffin’ back to Dun Laoghaire as charter fleet expands

MarineServices brings workboat ‘Puffin’ back to Dun Laoghaire as charter fleet expands

MarineServices.ie has acquired the workboat Puffin and returned it to Dún Laoghaire, expanding its commercial vessel charter fleet. The vessel holds an Irish Marine Survey Office P5 licence and is equipped with certified lifting gear, including a 4-ton winch and 2.1-ton crane. Puffin previously served the Commissioners of Irish Lights and supported offshore buoy operations since 1984.
31 December 2025
AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin shares fell 1.3% to $685 in thin year-end trading Wednesday, underperforming major indexes as investors rotated out of high-growth tech stocks. Treasury yields rose after jobless claims dropped to 199,000, pressuring growth shares further. The Invesco QQQ Trust and S&P 500-tracking SPDR fund each slipped about 0.2% in afternoon trading.
Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital shares climbed 4.6% to $25.20 Wednesday afternoon, outperforming a weaker market after Northland and Lake Street reiterated bullish ratings ahead of the Jan. 7 earnings call. The company recently signed a non-binding term sheet to spin out its cloud unit and merge it with EKSO Bionics, forming ChronoScale, a GPU-accelerated cloud platform. Applied Digital expects to own 97% of the new entity.
31 December 2025
Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept shares plunged nearly 50% to $35.31 after the FDA rejected relacorilant for Cushing’s-related hypertension, citing insufficient evidence of effectiveness. The move erased about $3.7 billion in market value. Corcept said it will meet with the FDA to discuss next steps. The company is also awaiting a July 2026 FDA decision on relacorilant in ovarian cancer.
Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

Santa Claus Rally Fizzles: S&P 500, Dow Slip as Tech Weighs on 2025 Finale

Wall Street’s main indexes slipped in thin trading on December 31, with the Dow down 116 points by midday, as Microsoft and Apple led declines. Despite the late-year dip, major indexes remained on track for double-digit gains in 2025. Investors shifted focus to the Federal Reserve’s 2026 outlook after minutes revealed divisions over further rate cuts. AI and chip stocks drove much of the year’s rally, while some firms lagged sharply.
JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan shares rose 0.3% to $324.25 in afternoon trading Wednesday, outperforming major U.S. banks. Treasury yields climbed after weekly jobless claims dropped to 199,000, below forecasts. The Federal Reserve minutes showed officials divided over the 2026 rate outlook. Investors await JPMorgan’s earnings on Jan. 13 and the Fed’s Jan. 27–28 meeting.
IREN stock slips in New York trade as bitcoin eases into year-end

IREN stock slips in New York trade as bitcoin eases into year-end

IREN shares fell about 1% to $37.92 Wednesday afternoon, tracking a 0.6% drop in bitcoin, which traded near $87,688. U.S.-listed bitcoin miners were mixed as year-end portfolio adjustments continued. Marathon Digital and CleanSpark declined, while Riot Platforms gained. IREN traded between $37.58 and $38.98, with 12.7 million shares changing hands by early afternoon.

Stock Market Today

  • ASX Penny Stocks Over A$10M Market Cap Showing Potential Despite Market Slump
    April 29, 2026, 10:49 PM EDT. The Australian share market faces a 0.7% decline, hitting approximately 8,600 points over seven days. Investors eye penny stocks-smaller companies with market caps above A$10 million-for growth potential. Connected Minerals Limited (ASX:CML), with a A$19.82 million market cap, operates in Namibia and WA, remains debt-free and liquid despite rising losses. HMC Capital Limited (ASX:HMC), valued at A$1.02 billion, manages real estate funds and digital assets, reduces losses 48.1% annually, and maintains strong liquidity with a 56.7x EBIT interest coverage ratio. Both stocks represent firms with financial resilience and long-term value in challenging markets.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop